Schedule H Prescription Drug - Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
Gluomni M2
Composition
Glimepiride IP 2 mg and Metformin Hydrochloride IP 500 mg as prolonged release, along with approved excipients
Dosage Strength
2 mg & 500 mg
Medicine Type
Tablet
Pack Size
10 X 10 Tablets
Storage Instructions
Gluomni-M2 Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP should be stored protected from light and moisture at a temperature not exceeding 30°C.
Caution
The medicine must be kept out of reach of children and used only as directed by the physician.
Product Information
Gluomni-M2 by EMK Omni Pharma is a prescription-based Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP formulation used for doctor-supervised type 2 diabetes management, blood sugar control, and long-term glycaemic support. Each uncoated bilayered tablet contains Glimepiride IP 2 mg and Metformin Hydrochloride IP 500 mg as prolonged release. Gluomni-M2 is commonly prescribed by healthcare professionals for patients who require support in managing high blood glucose levels, insulin resistance, glucose imbalance, and type 2 diabetes care. Gluomni-M2 Glimepiride 2 mg and Metformin 500 mg Tablets by EMK Omni Pharma are designed for physician-guided diabetes treatment where dual-action blood sugar management and sustained glucose control are required. This medicine should be used only as advised by a registered medical practitioner. Gluomni-M2 may be prescribed by doctors for patients who require support in managing type 2 diabetes, high blood sugar levels, insulin resistance, glucose imbalance, and long-term glycaemic control. It may be used as part of a complete physician-guided diabetes care plan that includes medication, diet management, exercise, lifestyle correction, and regular blood sugar monitoring. Gluomni-M2 by EMK Omni Pharma is suitable for doctor-supervised treatment where blood glucose control, diabetes management, and sustained metabolic support are required. Patients should not self-medicate, change the dosage, stop the medicine, or combine it with other diabetes medicines without consulting their doctor.
Medical Disclaimer
This product information is intended for general awareness only and should not be considered medical advice. Please consult a registered medical practitioner before using any prescription medicine.